Issue navigation
Volume 34, Issue 1, January 2024
Review Articles
Japan College of Rheumatology guidance for the use of methotrexate in patients with rheumatoid arthritis: Secondary publication
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 1–10, https://doi.org/10.1093/mr/road098
Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor: A narrative review
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 11–26, https://doi.org/10.1093/mr/road033
Original Article
Rheumatoid arthritis
Socioeconomic impact of treatment with biological disease–modifying antirheumatic drugs in Japanese patients with rheumatoid arthritis
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 27–36, https://doi.org/10.1093/mr/roac160
Long-term safety and efficacy of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to methotrexate
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 37–44, https://doi.org/10.1093/mr/road004
Long-term evaluation of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 45–49, https://doi.org/10.1093/mr/road005
Clinical and immunological effects of hydroxychloroquine in patients with active rheumatoid arthritis despite antirheumatic treatment
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 50–59, https://doi.org/10.1093/mr/roac153
Factors associated with impaired physical function in elderly rheumatoid arthritis patients who had achieved low disease activity
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 60–67, https://doi.org/10.1093/mr/roac151
The effect of smoking on response to methotrexate in rheumatoid arthritis patients: A systematic review and meta-analysis
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 68–78, https://doi.org/10.1093/mr/road013
Single-centre, cross-sectional study on the factors and reasons for non-vaccination among patients with rheumatoid arthritis
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 79–86, https://doi.org/10.1093/mr/road003
Illustrations of rheumatoid arthritis symptoms to promote communication between patients and physicians
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 87–91, https://doi.org/10.1093/mr/roac152
Radiographic study of the distal ulna in rheumatoid arthritis with extensor digitorum communis ruptures
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 92–96, https://doi.org/10.1093/mr/roac139
Connective Tissue Diseases
Severe COVID-19 in patients with immune-mediated rheumatic diseases: A stratified analysis from the SORCOM multicentre registry
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 97–105, https://doi.org/10.1093/mr/roac148
Polypharmacy prevalence and associated factors in patients with systemic lupus erythematosus: A single-centre, cross-sectional study
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 106–112, https://doi.org/10.1093/mr/roac155
Factors associated with osteoporosis and fractures in patients with systemic lupus erythematosus: Kyoto Lupus Cohort
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 113–121, https://doi.org/10.1093/mr/road014
New aspects of clinical and immunological characteristics in patients with anti-asparaginyl tRNA synthetase (anti-KS) autoantibody
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 122–128, https://doi.org/10.1093/mr/road011
Increased expression of the p-STAT3/IL-17 signaling pathway in patients with dermatomyositis
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 129–136, https://doi.org/10.1093/mr/roac147
Hyperglobulinemia predicts increased risk of mortality in primary Sjögren’s syndrome: Based on a Chinese multicentre registry
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 137–143, https://doi.org/10.1093/mr/road010
Validation of new ACR/EULAR 2022 classification criteria for anti-neutrophil cytoplasmic antibody–associated vasculitis
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 144–150, https://doi.org/10.1093/mr/road017
Time to normalisation of C-reactive protein and incidence of relapse in microscopic polyangiitis: A medical records review study in Japan
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 151–156, https://doi.org/10.1093/mr/roac146
Evaluation of prognostic factors for patients with eosinophilic granulomatosis with polyangiitis recruited at the pneumonological centre and mainly ANCA negativity: A retrospective analysis of a single cohort in Poland
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 157–166, https://doi.org/10.1093/mr/road001
Nationwide clinical and epidemiological study of large-vessel vasculitis in Japan in 2017
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 167–174, https://doi.org/10.1093/mr/road019
Clinical and angiographic outcomes of mycophenolate versus methotrexate in South Asian patients of Takayasu arteritis: Results from an open-label, outcome-assessor blinded randomized controlled trial
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 175–181, https://doi.org/10.1093/mr/roac157
Recommendations for the management of the vascular involvement in Behçet’s disease by the Japanese National Research Committee for Behçet’s disease—secondary publication
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 182–193, https://doi.org/10.1093/mr/road002
Age-related differences in the clinical phenotypes of Behçet’s disease: The experience of two referral centres
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 194–200, https://doi.org/10.1093/mr/road012
Other Rheumatic and Musculoskeletal Diseases
Clinical features of polymyalgia rheumatica patients in Japan: Analysis of real-world data from 2015 to 2020
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 201–207, https://doi.org/10.1093/mr/road026
Clinical features and outcomes of spine surgery in patients with ankylosing spondylitis
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 208–213, https://doi.org/10.1093/mr/roac142
Disease severity and genotype–phenotype correlation in adult patients with familial Mediterranean fever
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 214–219, https://doi.org/10.1093/mr/road007
PREDICT-crFMF score: A novel model for predicting colchicine resistance in children with familial Mediterranean fever
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 220–225, https://doi.org/10.1093/mr/road008
Comparison of the clinical outcomes following total knee arthroplasty in osseous ankylosed and non-ankylosed knees using propensity-score matching
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 226–237, https://doi.org/10.1093/mr/roac144
Estimated excretion and clearance of uric acid as optimal surrogate indices for daily urinary uric acid excretion
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 238–244, https://doi.org/10.1093/mr/roac149
Letter
Real-world treatment of gout and asymptomatic hyperuricaemia in Japan
Modern Rheumatology, Volume 34, Issue 1, January 2024, Pages 245–246, https://doi.org/10.1093/mr/road006
